TY  - GEN
AU  - Sternberg,D W
AU  - Aird,W
AU  - Neuberg,D
AU  - Thompson,L
AU  - MacNeill,K
AU  - Amrein,P
AU  - Shulman,L N
TI  - Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen
SN  - 0008-543X
PY  - 2000///0601
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cause of Death
KW  - Cerebellar Diseases
KW  - chemically induced
KW  - Cytarabine
KW  - Death, Sudden, Cardiac
KW  - etiology
KW  - Disease-Free Survival
KW  - Drug Eruptions
KW  - Exanthema
KW  - Female
KW  - Humans
KW  - Injections, Intravenous
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Neoplasm Recurrence, Local
KW  - Neutropenia
KW  - Remission Induction
KW  - Thrombocytopenia
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/(sici)1097-0142(20000501)88:9<2037::aid-cncr8>3.0.co;2-k
ER  -